Stock COCP COCRYSTAL PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cocrystal Pharma, Inc.

Equities

COCP

US19188J4094

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.555 USD +2.98% Intraday chart for Cocrystal Pharma, Inc. +1.64% -9.71%
Mar. 28 Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 04 Cocrystal Pharma, Inc. Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investment Candidates CI

Evolution of the average Target Price on Cocrystal Pharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

058530c.xiym2pukdwFwYyMVUKXZAae8nrcrb6RY81rDCYLYThk.oh_Wn-PnNDkhLU5lG_WAOPSF1_VCNf47hh2SS8CpBkajf_7pr-8nQwYTTA~0856bf787f4b07c4a5dfde3bd488f417

Analyst Recommendations on Cocrystal Pharma, Inc.

HC Wainwright Adjusts Cocrystal Pharma's Price Target to $12 From $35, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Cocrystal Pharma to $35 From $42, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on Cocrystal Pharma to $42 From $48, Maintains Buy Rating MT
COCRYSTAL PHARMA : HC Wainwright Adjusts Cocrystal Pharma PT to $4 From $4.50, Maintains Buy Rating MT
COCRYSTAL PHARMA : HC Wainwright Adjusts Cocrystal Pharma Price Target to $4.50 From $5, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.555 USD
Average target price
8.667 USD
Spread / Average Target
+457.34%
High Price Target
10 USD
Spread / Highest target
+543.09%
Low Price Target
6 USD
Spread / Lowest Target
+285.85%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cocrystal Pharma, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. COCP Stock
  4. Consensus Cocrystal Pharma, Inc.